Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Research & Development (2019 - 2023)

Historic Research & Development for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $27.1 million.

  • ADC Therapeutics' Research & Development rose 16497.74% to $27.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $18.9 million, marking a year-over-year increase of 11357.2%. This contributed to the annual value of -$187898.0 for FY2022, which is 1892.13% down from last year.
  • Latest data reveals that ADC Therapeutics reported Research & Development of $27.1 million as of Q3 2023, which was up 16497.74% from $31.3 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Research & Development peaked at $35.4 million during Q1 2020, and registered a low of -$49.0 million during Q1 2022.
  • For the 5-year period, ADC Therapeutics' Research & Development averaged around -$15.2 million, with its median value being -$26.0 million (2020).
  • Its Research & Development has fluctuated over the past 5 years, first plummeted by 11915551.47% in 2020, then skyrocketed by 16497.74% in 2023.
  • Over the past 5 years, ADC Therapeutics' Research & Development (Quarter) stood at -$30424.0 in 2019, then crashed by 105589.59% to -$32.2 million in 2020, then surged by 99.87% to -$42492.0 in 2021, then fell by 14.69% to -$48733.0 in 2022, then soared by 55668.1% to $27.1 million in 2023.
  • Its last three reported values are $27.1 million in Q3 2023, $31.3 million for Q2 2023, and -$39.5 million during Q1 2023.